Genetic profiles of oligometastatic non-small-cell lung cancer and corresponding brain metastases
European Journal of Cardio-Thoracic Surgery · 2024
DOI: 10.1093/ejcts/ezae217 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2024. Verfasst von Raphael S Werner und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Brain Neoplasms, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Stiftung für angewandte Krebsforschung (SAKF) Zurich.
Abstract (Originalsprache)
OBJECTIVES In patients with oligometastatic non-small-cell lung cancer (NSCLC), systemic therapy in combination with local ablative treatment of the primary tumour and all metastatic sites is associated with improved prognosis. For patient selection and treatment allocation, further knowledge about the molecular characteristics of the oligometastatic state is necessary. Here, we performed a genetic characterization of primary NSCLC and corresponding brain metastases (BM). METHODS We retrospectively identified patients with oligometastatic NSCLC and synchronous (<3 months) or metachronous (>3 months) BM who underwent surgical resection of both primary tumour and BM. Mutation profiling of formalin-fixed paraffin-embedded tumour cell blocks was performed by targeted next-generation sequencing using the Oncomine Focus Assay panel. RESULTS Sequencing was successful in 46 paired samples. An oncogenic alteration was present in 31 primary tumours (67.4%) and 40 BM (86.9%). The alteration of the primary tumours was preserved in the corresponding BM in 29 out of 31 cases (93.5%). The most prevalent oncogenic driver in both primary tumours and BM was a KRAS (Kirsten rat sarcoma viral oncogene) mutation (s = 21). In 16 patients (34.8%), the BM harboured additional oncogenic alterations. The presence of a private genetic alteration in the BM was an independent predictor of shorter overall survival. CONCLUSIONS In oligometastatic NSCLC, BM retain the main genetic alterations of the primary tumours. Patients may profit from targeted inhibition of mutated KRAS. Additional private genetic alterations in the BM are dismal.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland.
- Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
- Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
- Department of Neurology and Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
- Department of Neurosurgery, University Hospital Zurich, Zurich, Switzerland.
- Department of Pathology, University Hospital Essen, Essen, Germany.
ORCID-Profile: Michael Weller, Luca Regli, Emilie Le Rhun, Isabelle Opitz
Förderung
- Stiftung für angewandte Krebsforschung (SAKF) Zurich
Zitieren
APA
Werner, R. S., Rechsteiner, M., Moch, H., Curioni-Fontecedro, A., Weller, M., Weiss, T., Regli, L., Le Rhun, E., Mairinger, F., Opitz, I., & Soltermann, A. (2024). Genetic profiles of oligometastatic non-small-cell lung cancer and corresponding brain metastases. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezae217
Vancouver
Werner RS, Rechsteiner M, Moch H, Curioni-Fontecedro A, Weller M, Weiss T, et al. Genetic profiles of oligometastatic non-small-cell lung cancer and corresponding brain metastases. European Journal of Cardio-Thoracic Surgery. 2024. doi:10.1093/ejcts/ezae217
BibTeX
@article{Werner2024,
author = {Werner, Raphael S and Rechsteiner, Markus and Moch, Holger and Curioni-Fontecedro, Alessandra and Weller, Michael and Weiss, Tobias and Regli, Luca and Le Rhun, Emilie and Mairinger, Fabian and Opitz, Isabelle and Soltermann, Alex},
title = {Genetic profiles of oligometastatic non-small-cell lung cancer and corresponding brain metastases},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2024},
doi = {10.1093/ejcts/ezae217}
}
EUVIMED